Berbamine inhibits SARS-CoV-2 infection by compromising TRPMLs-mediated endolysosomal trafficking of ACE2

Signal Transduct Target Ther. 2021 Apr 24;6(1):168. doi: 10.1038/s41392-021-00584-6.

Lihong Huang^#^{1

2}, Terrence Tsz-Tai Yuen^#³, Zuodong Ye^#^{1

2}, Shuyan Liu^#⁴, Guoliang Zhang⁴, Hin Chu⁵, Jianbo Yue^{6

7}

¹ City University of Hong Kong Shenzhen Research Institute, Shenzhen, China.
² Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
³ Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
⁴ National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
⁵ Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China. hinchu@hku.hk.
⁶ City University of Hong Kong Shenzhen Research Institute, Shenzhen, China. jianbyue@cityu.edu.hk.
⁷ Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China. jianbyue@cityu.edu.hk.

^# Contributed equally.

No abstract available

Publication types